ArticleMolecular and cellular biochemistry2013

Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6.

Jingmei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.